The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces

Journal of the American College of Cardiology

Volumn 33, Issue 5, 1999, Pages 1408-1414

  Maalej, Nabil ^a   Albrecht, Ralph ^a,c   Loscalzo, Joseph ^a,b,d   Folts, John D ^a,b  

^a Umversity of Wisconsin Medical School ^*

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c School of Medicine ^*  (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CYCLIC GMP;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOGENESIS;

EID: 0033117112     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00687-1     Document Type: Article

References (36)

1. Myers PR, Minor RL, Guerra R Jr, Bates N, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrosocysteine than nitric oxide. Nature 1990;345:161-3.
2. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 1987;92:181-7.
3. Stamler JS, Loscalzo J. The antiplatelet effects of organic nitrates and related nitroso-compounds in vitro and in vivo and their relevance to cardiovascular disorders. J Am Coll Cardiol 1991;18:1529-36.
4. Folts JD, Stamler JS, Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed dog coronary arteries. Circulation 1991;83:2122-7.
5. Rovin JD, Stamler JS, Loscalzo J, Folts JD. Sodium nitroprusside, an endothelium relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries. J Cardiovasc Pharmac 1993;22:626-31.
6. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat smooth muscle cells. J Clin Invest 1989;83:1774-7.
7. Amiji M, Park H, Park K. Study on the prevention of surface induced platelet activation by albumin coating. J Biomater Sci Polymer 1992;3:375-88.
8. Riccitelli SD, Schlatterer RG, Hendrix JA, Williams GB, Eberhart RC. Albumin coatings resistant to shear-induced desorption. Trans Am Soc Artif Intern Organs 1985;31:250-6.
9. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci 1992;89:444-8.
10. Marks DS, Vita JA, Folts JD, Keaney JF Jr, Welch GN, Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 1995;96:2630-8.
11. Folts JD. Coating Palmaz-Schatz stents with a unique NO donor reduces the need for post-procedure anticoagulation when placed in pig carotid arteries. J Invest Med 1995;43:476A.
12. Folts JD, Keaney JF, Loscalzo J. Local delivery of nitrosated albumin to stenosed and damaged coronary arteries inhibits platelet deposition and thrombosis [special edition]. Jam Col Card 1995;377A.
13. Albrecht RM, Goodman SL, Simmons SR. Distribution and movement of membrane-associated platelet glycoproteins: use of colloidal gold with correlative video-enhanced light microscopy, low-voltage high-resolution scanning electron microscopy, and high-voltage transmission electron microscopy. Amer J Anat 1989;185:149-64.
14. Olorundare OE, Simmons SR, Albrecht RM. Cytochalasin D and E: effects on fibrinogen receptor movement and cytoskeletal reorganization in fully spread, surface-activated platelets: a correlative light and electron microscopic investigation. Blood 1992;79:99-109.
15. Heyns AP. Method for labeling platelets with In111-oxine. In: Heyns AP, Badenhorst PN, Lotter MG, editors. Platelet Kinetics and Imaging, VI. Boca Raton, Florida: CRC Press, 1985:153-7.
16. Park K, Mosher DF, Cooper S. Acute surface-induced thrombosis in the canine ex vivo model: importance of protein composition of the initial monolayer and platelet activation. J Biom Mat Res 1986;20:589-612.
17. Brash JL. Protein interactions with artificial surfaces. In: Salzman EW, editor. Interaction of the Blood With Natural and Artificial Surfaces. New York: Marcel Dekker, Inc., 1981:37.
18. Brynda E, Houska M, Pokorrna Z, Cepalova NA, Moiseev YV, Kalal J. Irreversible adsorption of human serum albumin onto polyethylene film. J Bioeng 1978;2:411-8.
19. Ihlenfeld JV, Cooper SL. Transient in vivo protein adsorption onto polymeric biomaterials. J Biomed Materials Res 1979;13:577-91.
20. Ishikawa Y, Sasakawa S, Takase M, Osada Y. Effective albumin immobilization by plasma polymerization on platelet reactivity. Thromb Res 1984;35:193-202.
21. Groves PH, Penny WJ, Cheadle HA, Lewis MJ. Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplasty. Cardio Res 1992;26:615-9.
22. Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057-8.
23. Lam JY, Chesebro JH, Fuster V. Platelets, vasoconstriction and nitroglycerin during arterial wall injury. A new antithrombotic role of an old drug. Circulation 1988;78:712-6.
24. DeCaterin R, Giannessi D, Bernini W, Lazzerini G, Mazzone A, Lombardi M. In vivo actions of organic nitrates on platelet function in humans. Z Kardiol 1989;78 Suppl 2:56-60.
25. Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. Br J Pharmacol 1986;88:411-5.
26. Korbut R, Lidbury PS, Vane JR. Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodialators. Lancet 1990;335:669.
27. Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 1985;76:703-8.
28. Keaney JF Jr, Simon DI, Stamler JS, et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993;91:1582-9.
29. Mellion BT, Ignarro LJ, Ohlstein EH, Pontecorvo EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981;57:946-55.
30. Nakashima S, Tohmatsu T, Hattori H, Okano Y, Nozawa Y. Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin stimulated human platelet. Biochem Biophys Res Commun 1986;135:1099-104.
31. Morgan RO, Newby AC. Nitroprusside differentially inhibits ADP-stimulated calcium influx and mobilization in human platelets. Biochem J 1989;258:447-54.
32. Keany JF, Stamler JS, Scharfstein J, Folts JD, Loscalzo J. NO forms a stable adduct with serum albumin that has potent antiplatelet properties in vivo. Clin Res 1992;40:194A.
33. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
34. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990;336:897-900.
35. Barnes MJ. Collagen in atherosclerosis. Collagen Rel Res 1985;5:65-97.
36. Alevriadou BR, Moake JL, Turner NA, et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of vonWillebrand factor binding to platelets. Blood 1993;81:1263-76.